Evidence map›Paper›PMID 32238909›Full record

ArticleEuropean journal of human genetics : EJHG2020

A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability.

Katherine A Benson, Maire White, Nicholas M Allen, Susan Byrne, Robert Carton, Elizabeth Comerford, Daniel Costello, Colin Doherty, Brendan Dunleavey, Hany El-Naggar and 17 more

Abstract readComparative Study
In one paragraph

Article in European journal of human genetics : EJHG, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Epilepsy-associatedFrontiers in neurology · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Germline mosaicism in a family withCold Spring Harbor molecular case studies · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Katherine A BensonSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Maire WhiteSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Nicholas M AllenDepartment of Paediatrics, National University of Ireland Galway, Galway University Hospital, Galway, Ireland.
Susan ByrneSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Robert CartonSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Elizabeth ComerfordSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Daniel CostelloDepartment of Neurology, Cork University Hospital & University College Cork, Cork, Ireland.
Colin DohertyDepartment of Neurology, St James' Hospital, Dublin, Ireland.
Brendan DunleaveyErgo IT Services, Dublin, Ireland.
Hany El-NaggarSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Nisha GangadharanSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Sinéad HeavinSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Hugh KearneySchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Nicholas J LenchCongenica Ltd, Wellcome Genome Campus, Hinxton, Cambridge, UK.
John LynchDepartment of Neurology, University Hospital Galway, Galway, Ireland.
Mark McCormackSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Mary O' ReganOur Lady's Children's Hospital Crumlin, Dublin, Ireland.
Karl PodestaMicrosoft, Dublin, Ireland.
Kevin PowerSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Anthony S RogersCongenica Ltd, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Charles A StewardCongenica Ltd, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID http://orcid.org/0000-0001-8829-5349
Brian SweeneyDepartment of Neurology, Cork University Hospital & University College Cork, Cork, Ireland.
David WebbOur Lady's Children's Hospital Crumlin, Dublin, Ireland.ORCID http://orcid.org/0000-0002-0762-8277
Mary FitzsimonsSchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Marie GreallySchool of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Norman Delanty *School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Gianpiero L Cavalleri *School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland. gcavalleri@rcsi.ie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Next generation sequencing provides an important opportunity for improved diagnosis in epilepsy. To date, the majority of diagnostic genetic testing is conducted in the paediatric arena, while the utility of such testing is less well understood in adults with epilepsy. We conducted whole exome sequencing (WES) and copy number variant analyses in an Irish cohort of 101 people with epilepsy and co-morbid intellectual disability to compare the diagnostic yield of genomic testing between adult and paediatric patients. Variant interpretation followed American College of Medical Genetics and Genomics (ACMG) guidelines. We demonstrate that WES, in combination with array-comparative genomic hybridisation, provides a diagnostic rate of 27% in unrelated adult epilepsy patients and 42% in unrelated paediatric patients. We observe a 2.7% rate of ACMG-defined incidental findings. Our findings indicate that WES has similar utility in both adult and paediatric cohorts and is appropriate for diagnostic testing in both epilepsy patient groups.

Indexed as

AdolescentAdultChildChild, PreschoolComorbidityComparative Genomic HybridizationEpilepsyExome SequencingFemaleGenetic TestingHumansInfantIntellectual DisabilityMaleMiddle AgedMutation

Identifiers

PMID32238909
PMCPMC7381648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.